Загрузка...
The Future of Respiratory Syncytial Virus Disease Prevention and Treatment
Respiratory syncytial virus (RSV) is a major cause of respiratory tract infections in infants, young children, and older or immunocompromised adults. Although aerosolized ribavirin was licensed for RSV treatment on the basis of data demonstrating a reduced need for supplemental oxygen, ribavirin use...
Сохранить в:
| Опубликовано в: : | Infect Dis Ther |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Healthcare
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7926075/ https://ncbi.nlm.nih.gov/pubmed/33656652 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-020-00383-6 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|